Abstract
The widespread detection of perfluorinated acids (PFAs) in humans and known developmental toxicity in animals has raised concern about their potential effects on human reproductive health. Our objective was to determine whether increasing maternal exposure to PFAs is associated with adverse effects on fetal growth and length of gestation in women giving birth in Alberta, Canada. We examined the concentrations of perfluorooctanoic acid (PFOA), perfluorooctane sulfonate (PFOS), and perfluorohexane sulfonate (PFHxS) in a cohort of 252 pregnant women who gave birth to live singletons. Each of the women had undergone an early second trimester prenatal screen, and her serum was analyzed for PFA concentrations. Data on infant and maternal variables were collected from the delivery record completed at birth. Adjusted changes in birth weight per natural log (ng/ml) of PFOA (median 1.5 ng/ml), PFHxS (median 0.97 ng/ml), and PFOS (median 7.8 ng/ml) were −37.4 g (95% confidence interval (CI): −86.0 to 11.2 g), 21.9 g (−23.4 to 67.2 g), and 31.3 g (−43.3 to 105.9 g), respectively. Mean birth weight z-score, standardized for gestational age and gender, length of gestation, and risk of preterm birth did not appear to be influenced by maternal PFA exposure. When PFA concentrations were divided into tertiles, similar patterns were observed. These results suggest that maternal PFA exposure has no substantial effect on fetal weight and length of gestation at the concentrations observed in this population.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Apelberg B.J., Witter F.R., Herstman J.B., Calafat A.M., Halden R.U., and Needham L.L., et al. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect 2007: 115: 1670–1676.
Case M.T., York R.G., and Christian M.S. Rat and rabbit oral developmental toxicology studies with two perfluorinated compounds. Int J Toxicol 2001: 20: 101–109.
Chan E., Sandhu M., Benskin J.P., Ralitsch M., Thibault N., and Birkholz D., et al. Endogenous high-performance liquid chromatography/tandem mass spectrometry interferences and the case of perfluorohexane sulfonate (PFHxS) in human serum; are we overestimating exposure? Rapid Commun Mass Spectrom 2009: 23: 1405–1410.
Dupont W.D., and Plummer W.D. PS power and sample size program available for free on the Internet. Controlled Clin Trials 1997: 18: 274.
Era S., Harada K.H., Toyoshima M., Inoue K., Minata M., and Saito N., et al. Cleft palate caused by perfluorooctane sulfonate is caused mainly by extrinsic factors. Toxicology 2009: 256: 42–47.
Fei C., McLaughlin J.K., Tarone R.E., and Olsen J. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect 2007: 115: 1677–1682.
Frisbee S.J., Brooks A.P., Maher A., Flensborg P., Arnold S., and Fletcher T., et al. The C8 Health Project: design, methods, and participants. Environ Health Perspect 2009 doi: 10.1289/ehp.0800379.
Gabos S., Zemanek M., Cheperdak L., Kinniburgh D., Lee B., and Hrudey S., et al. Chemical biomonitoring in serum of pregnant women in Alberta (2005). A final report submitted to Alberta Health and Wellness May 2008 http://www.health.alberta.ca/documents/Chemical-Biomonitoring-2008.pdf., 2008.
Grice M.M., Alexander B.H., Hoffbeck R., and Kampa D.M. Self-reported medical conditions in perfluorooctanesulfonyl fluoride manufacturing workers. J Occup Environ Med 2007: 49: 722–729.
Hansen K.J., Clemen L.A., Ellefson M.E., and Johnson H.O. Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices. Environ Sci Technol 2001: 35: 766–770.
Houde M., Martin J.W., Letcher R.J., Solomon K.R., and Muir D.C.G. Biological monitoring of perfluoroalkyl substances: a review. Environ Sci Technol 2006: 40: 3463–3473.
Inoue K., Okada F., Ito R., Kato S., Sasaki S., and Nakajima S., et al. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. Environ Health Perspect 2004: 112: 1204–1207.
Kennedy G.L., Butenhoff J.L., Olsen G.W., O’Connor J.C., Seacat A.M., and Perkins R.G., et al. The toxicology of perfluorooctanoate. Crit Rev Toxicol 2004: 34: 351–384.
Kramer M.S., Platt R.W., Wen S.W., Joseph K.S., Allen A., and Abrahamowicz M., et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 2001: 108: E35.
Lau C., Thibodeaux J.R., Hanson R.G., Rogers J.M., Grey B.E., and Stanton M.E., et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. Toxicol Sci 2003: 74: 382–392.
Midasch O., Drexler H., Hart N., Beckmann M.W., and Angerer J. Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study. Int Arch Occup Environ Health 2007: 80: 643–648.
Monroy R., Morrison K., Teo K., Atkinson S., Kubwabo C., and Stewart B., et al. Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environ Res 2008: 108: 56–62.
Nolan L.A., Nolan J.M., Shofer F.S., Rodway N.V., and Emmett E.A. The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water. Reprod Toxicol 2009: 27: 231–238.
Olsen G.W., Burris J.M., Ehresman D.J., Froehlich J.W., Seacat A.M., and Butenhoff J.L., et al. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexane sulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 2007: 115: 1298–1305.
Olsen G.W., Mair D.C., Church T.R., Ellefson M.E., Reagen W.K., and Boyd T.M., et al. Decline in perfluorooctanesulfonate and other polyfluoroalkyl chemicals in American Red Cross adult blood donors, 2000–2006. Environ Sci Technol 2008: 42: 4989–4995.
Olsen G.W., Butenhoff J.L., and Zobel L.R. Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives. Reprod Toxicol 2009: 27: 212–230.
Savitz D.A. Biomarkers of perfluorinated chemicals and birth weight. Environ Health Perspect 2007: 115: A528–A529.
Thibodeaux J.R., Hanson R.G., Rogers J.M., Grey B.E., Barbee B.D., and Richards J.H., et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. Toxicol Sci 2003: 74: 369–381.
Tough S., Tofflemire K., and Jack M. Reproduction in Alberta: a look at the preconception, prenatal and postnatal periods, 2006. Prepared for the Alberta Centre for Child, Family and Community Research. http://www.research4children.com/public/data/documents/ReproductioninAlberta20060620pdf.pdf (updated March 2007, viewed 13 October, 2009).
Washino N., Saijo Y., Sasaki S., Kato S., Ban S., and Konishi K., et al. Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth. Environ Health Perspect 2009: 117: 660–667.
Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004: 159: 702–706.
Acknowledgements
Igor Burstyn received salary support as a Population Health Investigator from the Alberta Heritage Foundation for Medical Research. Jonathan Martin received funding from NSERC Discovery, Alberta Health and Wellness, and the University Hospital Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Appendix
Appendix
Rights and permissions
About this article
Cite this article
Hamm, M., Cherry, N., Chan, E. et al. Maternal exposure to perfluorinated acids and fetal growth. J Expo Sci Environ Epidemiol 20, 589–597 (2010). https://doi.org/10.1038/jes.2009.57
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jes.2009.57
Keywords
This article is cited by
-
Re-expressing coefficients from regression models for inclusion in a meta-analysis
BMC Medical Research Methodology (2024)
-
Determinants of maternal and neonatal PFAS concentrations: a review
Environmental Health (2023)
-
Low-Level Environmental Per- and Polyfluoroalkyl Substances and Preterm Birth: A Nested Case–Control Study Among a Uyghur Population in Northwestern China
Exposure and Health (2022)
-
Reducing exposure to high levels of perfluorinated compounds in drinking water improves reproductive outcomes: evidence from an intervention in Minnesota
Environmental Health (2020)
-
Perfluoroalkyl substances exposure in early pregnancy and preterm birth in singleton pregnancies: a prospective cohort study
Environmental Health (2020)